Neuland Laboratories' Stock Soars 5.53%, Outperforms Sector and Sensex in One Day
Neuland Laboratories, a midcap pharmaceutical company, has gained 5.53% on October 31, 2024, outperforming the sector by 3.03%. With an intraday high of Rs 14495 and trading above all its moving averages, the stock has caught the attention of MarketsMojo, who have given a 'Buy' call. It has also outperformed the Sensex by 5.06% in one day and 21.91% in the past month, making it a promising investment option.
Neuland Laboratories, a midcap pharmaceutical company, has been making waves in the stock market with its recent performance. On October 31, 2024, the company's stock gained 5.53%, outperforming the sector by 3.03%. This positive trend has caught the attention of MarketsMOJO, who have given a 'Buy' call for the stock.
The stock's price summary for the day shows that it reached an intraday high of Rs 14495, a 4.99% increase from the previous day. This is a strong indication of the company's growth potential.
In terms of moving averages, Neuland Laboratories is currently trading higher than its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages. This is a positive sign for investors, as it shows a consistent upward trend in the stock's performance.
Compared to the overall market performance, Neuland Laboratories has outperformed the Sensex by 5.06% in just one day. In the past month, the company's stock has also outperformed the Sensex by 21.91%. This is a significant achievement for a midcap company in the pharmaceutical industry.
With its strong performance and positive outlook, Neuland Laboratories is definitely a stock to watch out for. Investors can take advantage of this opportunity and consider adding it to their portfolio.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
